Show simple item record

dc.contributor.authorWorld Health Assembly, 60
dc.coverage.spatialGenevaen
dc.date.accessioned2012-03-19T12:29:03Z
dc.date.available2012-03-19T12:29:03Z
dc.date.issued2007
dc.identifier.govdocA60/24
dc.identifier.urihttps://iris.who.int/handle/10665/22457
dc.descriptionWorld Health Assembly sixtieth session, provisional agenda item 12.17en
dc.language.isoenen
dc.publisherWorld Health Organizationen
dc.subjectPharmaceutical productsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrug Utilizationen
dc.subject.meshDrugs, Essentialen
dc.subject.meshDrug Resistance, Microbialen
dc.subject.meshInformation Systemsen
dc.titleProgress in the rational use of medicines: report by the Secretariaten
dc.typeGoverning body documentsen
dc.subject.meshqualifieradministration and dosageen
dc.subject.meshqualifiereconomicsen
dc.subject.meshqualifierstandardsen
who.relation.languageVersion10665/23430en
who.relation.languageVersion10665/23888en
who.relation.languageVersion10665/23459en
who.relation.languageVersion10665/25775en
who.relation.languageVersion10665/25685en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record